PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
1. Verfasser: | Lubaba, Anikah |
---|---|
Weitere Verfasser: | Fariha, Luluel Maknun |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
Brac University
2024
|
Schlagworte: | |
Online Zugang: | http://hdl.handle.net/10361/23252 |
Ähnliche Einträge
-
Effect of vitamin D, calcium and multiple micronutrients supplementation on lipid profile in pre-menopausal Bangladeshi garment factory workers with hypovitaminosis D
von: Islam, Md Zahirul, et al.
Veröffentlicht: (2017) -
Post Covid-19 health indications of Covid-19 patients
von: Khan, Tanzim
Veröffentlicht: (2022) -
Heart disease prediction using machine learning algorithms
von: Ali, Musfiq, et al.
Veröffentlicht: (2019) -
হার্ট, ব্লাড, ফুড /
von: কাসেম, এম এ -
Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
von: Shomi, Iffat Ara
Veröffentlicht: (2019)